Type of Study:
Device
Study Length:
5 years
Target Age/Sex:
Male or Female over the age of 18
Benefits:
Participants will receive at no cost: Study product, study visits, and study specific procedures. Participants may also receive compensation for their time and travel.
Staus: Enrolling
Description:
A durability study with the FDA approved Altaviva device for the treatment of overactive bladder or urge incontinence.